Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis

International Journal of Oncology

Volumn 32, Issue 3, 2008, Pages 575-583

  Krona, Cecilia ^a   Carén, Helena ^a   Sjöberg, Rose Marie ^a   Sandstedt, Bengt ^b   Laureys, Genevieve ^c   Kogner, Per ^b   Martinsson, Tommy ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Multifocal tumour; Neural crest cell; Neuroblastoma; PHOX2B; Tumour progression

Indexed keywords

BUSULFAN; HOMEODOMAIN PROTEIN; MELPHALAN; PAIRED LIKE HOMEOBOX 2 B PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CHROMOSOME 15; CHROMOSOME 17Q; CHROMOSOME 3; CHROMOSOME 4P; CHROMOSOME 9; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION; GENETIC GAIN; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HISTOPATHOLOGY; HOMEOBOX; HUMAN; MASS SCREENING; MISSENSE MUTATION; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

EID: 40249110396     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.3.575     Document Type: Article

References (35)